Data from Tgfbr1 Haploinsufficiency Is a Potent Modifier of Colorectal Cancer Development

Authors:
  • QZQinghua Zeng
    Qinghua Zeng
  • SPSharbani Phukan
    Sharbani Phukan
  • YXYanfei Xu
    Yanfei Xu
  • MSMaureen Sadim
    Maureen Sadim
  • DRDiana S. Rosman
    Diana S. Rosman
  • MPMichael Pennison
    Michael Pennison
  • JLJie Liao
    Jie Liao
  • GYGuang-Yu Yang
    Guang-Yu Yang
  • CHChiang-Ching Huang
    Chiang-Ching Huang
  • LVLaura Valle
    Laura Valle
  • ACAntonio Di Cristofano
    Antonio Di Cristofano
  • ACAlbert de la Chapelle
    Albert de la Chapelle

Abstract
Transforming growth factor-β (TGF-β) signaling is frequently altered in colorectal cancer. Using a novel model of mice heterozygous for a targeted null mutation of Tgfbr1 crossed with ApcMin/+ mice, we show that ApcMin/+;Tgfbr1+/− mice develop twice as many intestinal tumors as ApcMin/+;Tgfbr1+/+ mice, as well as adenocarcinoma of the colon, without loss of heterozygosity at the Tgfbr1 locus. Decreased Smad2 and Smad3 phosphorylation and increased cellular proliferation are observed in the colonic epithelium crypts of ApcMin/+; Tgfbr1+/− mice. Smad-mediated TGF-β signaling is preserved in both ApcMin/+;Tgfbr1+/+ and ApcMin/+;Tgfbr1+/− intestinal tumors, but cyclin D1 expression and cellular proliferation are significantly higher in ApcMin/+;Tgfbr1+/− tumors. These results show that constitutively reduced Tgfbr1-mediated TGF-β signaling significantly enhances colorectal cancer development and results in increased tumor cell proliferation. These findings provide a plausible molecular mechanism for colorectal cancer development in individuals with constitutively altered TGFBR1 expression, a recently identified common form of human colorectal cancer. [Cancer Res 2009;69(2):678–86]